chlorotrianisene has been researched along with Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
EVANS, AT; RUSH, TW; SMITH, PG | 1 |
Alken, CE; Dhom, G; Hohbach, M; Sachse, D; Schröder, FH; Straube, W | 1 |
2 other study(ies) available for chlorotrianisene and Carcinoma
Article | Year |
---|---|
Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma.
Topics: ADAM Proteins; ADAM17 Protein; Carcinoma; Chlorotrianisene; Embolization, Therapeutic; Estrogens; Humans; Male; Prostate; Prostatic Neoplasms | 1951 |
[Therapy and follow-up study of the prostatic neoplasm].
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma; Cell Nucleus; Chlorotrianisene; Estradiol; Evaluation Studies as Topic; Follow-Up Studies; Humans; Inclusion Bodies; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Radiotherapy, High-Energy; Stilbenes; Testis | 1972 |